BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19465121)

  • 1. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants.
    Srinarong P; Faber JH; Visser MR; Hinrichs WL; Frijlink HW
    Eur J Pharm Biopharm; 2009 Sep; 73(1):154-61. PubMed ID: 19465121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and physicochemical evaluation of a new tacrolimus tablet formulation for sublingual administration.
    Srinarong P; Pham BT; Holen M; van der Plas A; Schellekens RC; Hinrichs WL; Frijlink HW
    Drug Dev Ind Pharm; 2012 Apr; 38(4):490-500. PubMed ID: 21961909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid dispersions based on inulin for the stabilisation and formulation of delta 9-tetrahydrocannabinol.
    van Drooge DJ; Hinrichs WL; Wegman KA; Visser MR; Eissens AC; Frijlink HW
    Eur J Pharm Sci; 2004 Mar; 21(4):511-8. PubMed ID: 14998582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
    Owusu-Ababio G; Ebube NK; Reams R; Habib M
    Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of dissolution enhancement of itraconazole by solid dispersion in superdisintegrants.
    Chowdary KP; Rao SS
    Drug Dev Ind Pharm; 2000 Nov; 26(11):1207-11. PubMed ID: 11068695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of dissolution profile by solid dispersion (kneading) technique.
    Modi A; Tayade P
    AAPS PharmSciTech; 2006 Aug; 7(3):68. PubMed ID: 17025249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
    Mallick S; Sahu A; Pal K
    Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
    Sammour OA; Hammad MA; Megrab NA; Zidan AS
    AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of dissolution rate of hydrochlorothiazide via solid dispersion.
    Abd el-Fattah S; Boraie NA; Hassan HM
    Pharmazie; 1986 Nov; 41(11):790-3. PubMed ID: 3562513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions.
    van Drooge DJ; Hinrichs WL; Frijlink HW
    J Control Release; 2004 Jul; 97(3):441-52. PubMed ID: 15212876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the dissolution behaviour of tablets containing the drug in a polyethyleneglycol solid dispersion with direct compressed tablets.
    Kinget R
    Pharm Acta Helv; 1989; 64(3):90-3. PubMed ID: 2726990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.
    Vogt M; Kunath K; Dressman JB
    Eur J Pharm Biopharm; 2008 Feb; 68(2):283-8. PubMed ID: 17574403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation.
    Nepal PR; Han HK; Choi HK
    Int J Pharm; 2010 Jan; 383(1-2):147-53. PubMed ID: 19781608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion.
    Sammour OA; Hammad MA; Zidan AS; Mowafy AG
    Pharm Dev Technol; 2011 Jun; 16(3):219-27. PubMed ID: 20163325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-active derivative of inulin (Inutec® SP1) is a superior carrier for solid dispersions with a high drug load.
    Srinarong P; Hämäläinen S; Visser MR; Hinrichs WL; Ketolainen J; Frijlink HW
    J Pharm Sci; 2011 Jun; 100(6):2333-42. PubMed ID: 21254065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of solid dispersion technique in the preparation of therapeutic tablets. Part 1: Paracetamol, amylobarbitone, and caffeine tablets.
    El-Banna HM; Eshra AG; Hammouda Y
    Pharmazie; 1977; 32(8-9):511-5. PubMed ID: 145597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.